Online education improves pediatric residents' understanding of atopic dermatitis

Atopic Dermatitis

Pediatric Contact Dermatitis Registry Data on Contact Allergy in Children With Atopic Dermatitis

JAMA Dermatol.

Jacob SE, McGowan M, Silverberg NB, Pelletier JL, Fonacier L, Mousdicas N, Powell D, Scheman A, Goldenberg A

doi: 10.1001/jamadermatol.

Atopic Dermatitis

Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial

JAMA Pediatr.

Chan S, Cornelius V, Cro S, Harper JI, Lack G

doi: 10.1001/jamapediatrics.2019.4476.

Atopic Dermatitis

Texting atopic dermatitis patients to optimize learning and eczema area and severity index scores: A pilot randomized control trial

Pediatr Dermatol.

Singer HM, Levin LE, Morel KD, Garzon MC, Stockwell MS, Lauren CT

doi: 10.1111/pde.13510.

Atopic Dermatitis

Nemolizumab plus topical agents in patients with atopic dermatitis and moderate-to-severe pruritus provide improvement in pruritus and signs of atopic dermatitis for up to 68 weeks: results from two phase III, long-term studies

Br J Dermatol

Kabashima K, Matsumura T, Komazaki H, Kawashima M, Nemolizumab JP01, JP02 Study Group.

doi: 10.1111/bjd.20873

Atopic Dermatitis

Contact Dermatitis in Atopic Dermatitis Children-Past, Present, and Future

Clin Rev Allergy Immunol.

Borok J, Matiz C, Goldenberg A, Jacob SE

doi: 10.1007/s12016-018-8711-2.

Atopic Dermatitis

The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult, longstanding disease

J Am Acad Dermatol.

Brunner PM, He H, Pavel AB, Czarnowicki T, Lefferdink R, Erickson T, Canter T, Puar N, Rangel S, Malik K, Estrada Y, Krueger JG, Guttman-Yassky E, Paller AS

doi: 10.1016/j.jaad.

Atopic Dermatitis

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

J Eur Acad Dermatol Venereol.

Maksimovic N, Zaric M, Reljic V, Nikolic M, Gazibara T

doi: 10.1111/jdv.15939.

Atopic Dermatitis

Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial

Br J Dermatol.

Tsianakas A, Luger TA, Radin A

doi: 10.1111/bjd.15905.

Atopic Dermatitis

Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients

J Allergy Clin Immunol.

Guttman-Yassky E, Bissonnette R, Ungar B, Suárez-Fariñas M, Ardeleanu M, Esaki H, Suprun M, Estrada Y, Xu H, Peng X, Silverberg JI, Menter A, Krueger JG, Zhang R, Chaudhry U, Swanson B, Graham NMH, Pirozzi G, Yancopoulos GD, Hamilton JDD

doi: 10.1016/j.jaci.2018.08.022.

Related content

Pediatric Contact Dermatitis Registry Data on Contact Allergy in Children With Atopic Dermatitis

Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial

Texting atopic dermatitis patients to optimize learning and eczema area and severity index scores: A pilot randomized control trial

Nemolizumab plus topical agents in patients with atopic dermatitis and moderate-to-severe pruritus provide improvement in pruritus and signs of atopic dermatitis for up to 68 weeks: results from two phase III, long-term studies

Contact Dermatitis in Atopic Dermatitis Children-Past, Present, and Future

The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult, longstanding disease

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial

Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients